The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials

Published:2019-08 Issue: Volume:154 Page:101-115
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Maiorino Maria Ida,Chiodini Paolo,Bellastella Giuseppe,Scappaticcio Lorenzo,Longo Miriam,Giugliano Dario,Esposito Katherine

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference62 articles.

1. American Diabetes Association. 9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes 2019. Diabetes Care 2019;42(Suppl. 1):S90–S102. 10.2337/dc19-S009.

2. Insulin Glargine 4002 study investigators. The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients;Riddle;Diabetes Care,2003

3. A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes;Rosenstock;Diabetologia,2008

4. Insulin initiation in primary care for patients with type 2 diabetes: 3-year follow-up study;Dale;Prim Care Diabetes,2010

5. Glycemic control among patients with type 2 diabetes who initiate basal insulin: a retrospective cohort study;Curtis;J Med Econ,2014

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expert Opinion on Optimising Type 2 Diabetes Treatment Using Fixed-Ratio Combination of Basal Insulin and GLP-1 RA for Treatment Intensification and Simplification;Diabetes Therapy;2024-06-27

2. Open questions on basal insulin therapy in T2D: a Delphi consensus;Acta Diabetologica;2024-05-20

3. Comparison of GLP‐1 Receptor Agonists, SGLT‐2 Inhibitors, and DPP‐4 Inhibitors as an Add‐On Drug to Insulin Combined With Oral Hypoglycemic Drugs: Umbrella Review;Journal of Diabetes Research;2024-01

4. Real‐world study of the concomitant use of biphasic insulin as part 30/70 with GLP‐1 receptor agonist versus first‐generation basal insulin with GLP‐1 receptor agonist in type 2 diabetes;Diabetic Medicine;2023-12-13

5. Efficacy and safety of fixed‐ratio combination insulin degludec/liraglutide in type 2 diabetes: A systematic review and meta‐analysis of randomised controlled trials;Diabetes/Metabolism Research and Reviews;2023-11-27